Predictors of high-grade residual disease after repeat conization in patients with positive surgical margins

Ginekol Pol. 2022;93(12):962-967. doi: 10.5603/GP.a2022.0019. Epub 2022 Jul 27.

Abstract

Objectives: No consensus exists on the subsequent management strategy of patients who exhibit positive surgical margin (PSM) after re-excision of high-grade cervical intraepithelial neoplasia (CIN). The aim of the study is to examine the predictors related to the persistence of high-grade CIN lesions after re-excision, where PSM was left behind.

Material and methods: The present retrospective study included patients with PSM who underwent repeated conization due to residual high-grade CIN lesions between January 2005 and December 2019. The SPSS software v20.0 was used for data interpretation and statistical analysis. P values less than 0.05 were accepted as statistically significant.

Results: Repeat conization was performed in 91 patients, 43 (47.3%) presented with PSM with high-grade CIN, 6 (6.5%) presented with micro-invasive carcinoma, and 42 (46.2%) presented with clear surgical margin or CIN 1 at the surgical margin. At the time of conization, patients who presented with lesions > 5 mm in repeat cone specimens, exhibited a significantly higher rate of residual disease (p < 0.001). Besides, the involvement of the endocervical margin with high-grade CIN was the predictor of residual disease in repeat cone specimens (p = 0.006).

Conclusions: In the cone specimen, the presence of lesion size greater than 5 mm and involvement of the endocervical margin were the predictors of high-grade residual disease after re-excision. Whether it is the first or second procedure, great care must be given to excise the lesion entirely at the time of the conization, preferably in one piece.

Keywords: HPV infection and CIN; cancer of the cervix; cytology and GYN pathology.

MeSH terms

  • Conization / methods
  • Female
  • Humans
  • Margins of Excision
  • Neoplasm, Residual / surgery
  • Retrospective Studies
  • Uterine Cervical Dysplasia* / pathology
  • Uterine Cervical Neoplasms* / pathology
  • Uterine Cervical Neoplasms* / surgery